Page last updated: 2024-08-23

staurosporine and 3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one

staurosporine has been researched along with 3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elkamhawy, A; Farag, AK; Lee, KT; Londhe, AM; Pae, AN; Roh, EJ1

Other Studies

1 other study(ies) available for staurosporine and 3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one

ArticleYear
Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders.
    European journal of medicinal chemistry, 2017, Dec-01, Volume: 141

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cell Survival; Dose-Response Relationship, Drug; Inflammation; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Mice; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; RAW 264.7 Cells; Receptors, Colony-Stimulating Factor; Structure-Activity Relationship

2017